ConductScience.org, home

Paper20220189

Toward a personalized treatment of Hodgkin's disease.

DeVita VT and 1 other. N Engl J Med, 2010. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Toward a personalized treatment of Hodgkin's disease. Papers, record 20220189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20220189

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Toward a personalized treatment of Hodgkin's disease.
PubMed
Journal
N Engl J Med
PubMed
Year
2010
PubMed
Publication types
Comment, Editorial
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2026-01-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1DeVita VT JrVincent T
2Costa JJosé

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Antigens, Differentiation, MyelomonocyticMajor topic
Hodgkin DiseaseMajor topic
MacrophagesMajor topic
Disease-Free Survival
Gene Expression Profiling
Humans
Prognosis
Reed-Sternberg Cells
CD68 Molecule

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on20220182Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.https://conductscience.org/library/papers/20220182

Source PubMed

Download CSV of comments and corrections

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
36147921CD20 expression is closely associated with Epstein-Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma.Front Oncol2022https://conductscience.org/library/papers/36147921PubMed
32372254Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.J Egypt Natl Canc Inst2020https://conductscience.org/library/papers/32372254PubMed
29967610Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.Front Immunol2018https://conductscience.org/library/papers/29967610PubMed
27456130Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern.Am J Pathol2016https://conductscience.org/library/papers/27456130PubMed
25916750Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.Int J Exp Pathol2015https://conductscience.org/library/papers/25916750PubMed
21602260Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.Ann Oncol2012https://conductscience.org/library/papers/21602260PubMed
21542892Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances.Genome Med2011https://conductscience.org/library/papers/21542892PubMed
21318045Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.Adv Hematol2011https://conductscience.org/library/papers/21318045PubMed
20517336Hematology. Are macrophages the bad guys in Hodgkin lymphoma?Nat Rev Clin Oncol2010https://conductscience.org/library/papers/20517336PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20220189

GET https://conductscience.org/api/papers/v1/20220189/authors